Evidence map›Paper›PMID 40893435›Full record

ArticleStatistics in biosciences2024

Set-Based Tests for Genetic Association Studies with Interval-Censored Competing Risks Outcomes.

Zhichao Xu, Jaihee Choi, Ryan Sun

Abstract read
In one paragraph

Article in Statistics in biosciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Zhichao XuDepartment of Biostatistics, The University of Texas MD Anderson Cancer Center, 7007 Bertner Avenue, Houston, 77030, Texas, USA.
Jaihee ChoiDepartment of Statistics, Rice University, 6100 Main St., Houston, 77030, Texas, USA.
Ryan SunDepartment of Biostatistics, The University of Texas MD Anderson Cancer Center, 7007 Bertner Avenue, Houston, 77030, Texas, USA.

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI DIANE BODURKA · 1985 to 2026
$290.8M
Training Program in Biostatistics for Cancer ResearchT32CA096520 · NCI · RICE UNIVERSITY · PI KIMMEL, MAREK, YUAN, YING · 2003 to 2023
$4.5M
Innovative Statistical Analysis for Genome-Wide Data with Interval-Censored Outcomes of Oral Health in Childhood Cancer SurvivorsR03DE029238 · NIDCR · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI LI, YIMEI, SUN, RYAN · 2020 to 2021
$352k
NCI NIH HHS P30 CA016672NCI NIH HHS T32 CA096520NIDCR NIH HHS R03 DE029238
6 · The paper itself

Abstract

Over the past decade, massive genetic compendiums such as the UK Biobank have gathered extensive genetic and phenotypic data that hold the potential to provide unparalleled insight into the genetic etiologies of various complex diseases. However, much of the disease information is collected as time-to-event outcomes in interval-censored form, and conventional tools for genetic association analysis are often not available for this type of data. For example, set-based inference for common and rare variants analysis is a fundamental investigation in germline genetics studies, but there is a lack of approaches that can perform set-based testing when the interval-censored outcome of interest is subject to the competing risk of another event. To address the need, this work proposes two set-based inference procedures for interval-censored data with competing risks, applicable to rare variants and general genotype sets as well. The interval-censored competing risks sequence kernel association test (crSKAT) is a variance components approach that is powerful when genetic variants in a set demonstrate heterogeneous signals. The interval-censored competing risks Burden (crBurden) test is more powerful when variant signals are homogeneous. Simulation studies show the superiority of the newly developed methods in comparison to ad-hoc alternatives, as evidenced by their ability to control the type I error rate and to improve power. The proposed tests are applied to the UK Biobank to search for genes associated with fracture risk while accounting for death as a competing outcome.

Indexed as

Competing risksGenome-wide association studiesInterval-censoredSet-based inferenceTime-to-event

Identifiers

PMID40893435
PMCPMC12396347

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.